RIGL — Rigel Pharmaceuticals Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$29.17
Market Cap$540M
Float15.9M
Shares Outstanding18.5M
P/E (Forward)6.41
P/E (TTM)1.51
Price/Sales (TTM)1.80
vs. Analyst Target+82.4% to analyst PT
Profit Margin121.51%
Operating Margin (TTM)20.21%
Revenue (TTM)$300M
Earnings Growth (YoY)-30.20%
Dividend RateNone
Analyst Target Price$53.20 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $109M -$29.7M $108M -$27.7M
2021 $149M -$17.9M $148M -$11.3M
2022 $120M -$58.6M $118M -$53.9M
2023 $117M -$25.1M $110M -$17.0M
2024 $179M $17.5M $161M $28.5M
2025 $294M $367M $275M $132M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $102M $59.6M
Sep 2025 $69.5M $27.9M
Dec 2025 $69.8M $268M
Mar 2026 $58.8M $8.7M

Ownership & Float

Insider Ownership3.3%
Institutional Ownership94.3%
Short Float24.7%
% of All Funds Holding1.64%
Number of Funds Holding135

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$28.79Near-term / short-term trend
Weekly40-Week SMA$34.40Medium-term trend
Weekly80-Week SMA$27.86Cyclical trend (business cycle)
Weekly200-Week SMA$18.68Secular trend (multi-year)
Monthly10-Month SMA$34.68Near-term monthly trend
Monthly20-Month SMA$27.30Medium-term monthly trend
Monthly40-Month SMA$19.83Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$20.70 support 3.10x 8 months ago
$17.00 support 1.05x 15 months ago
$13.80 support 1.71x 17 months ago
$8.30 support 1.04x 21 months ago

Historical Earnings Reactions (102 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.89% 0.00% 49.02% 23.49% -12.66%
1 Day 1.70% 0.00% 48.04% 42.94% -16.81%
1 Week 1.43% -1.19% 43.14% 56.09% -24.60%
2 Weeks 0.60% -2.55% 42.16% 70.63% -49.26%
1 Month 1.03% -2.24% 46.53% 68.61% -59.73%

Next earnings: July 24, 2026 (58 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-2.1%38.5%26
Feb-3.0%42.3%26
Mar0.4%50.0%26
Apr2.9%53.8%26
May-0.2%32.0%25
Jun0.9%40.0%25
Jul0.0%52.0%25
Aug3.7%44.0%25
Sep1.9%48.0%25
Oct-5.7%40.0%25
Nov8.1%44.0%25
Dec12.1%46.2%26

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.09% 44.9% 1201
Tuesday -0.05% 45.4% 1315
Wednesday 0.26% 48.9% 1314
Thursday 0.23% 47.4% 1290
Friday 0.09% 45.0% 1286

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 94.3%

Insider Transactions — Smart Summary

Total insider ownership: 3.3%

12-Month Insider Activity Summary

Total Filings1
Net Value+N/A
Net Shares Change0
% of Float0.0%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
MOOS WALTER H -$49,440 1 1 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-02-24 MOOS WALTER H -$49,440 Transaction at $30.18, now -3.3%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Rigel Pharmaceuticals Inc (RIGL) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for RIGL on Trend Edge →